Lawrence G. Hamel
2014
In 2014, Lawrence G. Hamel earned a total compensation of $1.1M as Chief Development Officer at AcelRx Pharmaceuticals, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $65,695 |
|---|---|
| Option Awards | $693,723 |
| Salary | $310,250 |
| Other | $7,800 |
| Total | $1,077,468 |
Hamel received $693.7K in option awards, accounting for 64% of the total pay in 2014.
Hamel also received $65.7K in non-equity incentive plan, $310.3K in salary and $7.8K in other compensation.
Rankings
In 2014, Lawrence G. Hamel's compensation ranked 7,269th out of 13,032 executives tracked by ExecPay. In other words, Hamel earned more than 44.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,269 out of 13,032 | 44th |
Division Manufacturing | 2,679 out of 4,966 | 46th |
Major group Chemicals And Allied Products | 908 out of 1,686 | 46th |
Industry group Drugs | 714 out of 1,365 | 48th |
Industry Pharmaceutical Preparations | 550 out of 1,043 | 47th |
Source: SEC filing on April 28, 2017.
Hamel's colleagues
We found five more compensation records of executives who worked with Lawrence G. Hamel at AcelRx Pharmaceuticals in 2014.
2014
Timothy Morris
AcelRx Pharmaceuticals
Chief Financial Officer
2014
Richard King
AcelRx Pharmaceuticals
Chief Executive Officer
2014
Pamela Palmer
AcelRx Pharmaceuticals
Chief Medical Officer
2014
Badri Dasu
AcelRx Pharmaceuticals
Chief Engineering Officer
2014
James Welch
AcelRx Pharmaceuticals